Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Original Article

Downregulation of the MARC1 p.A165 risk allele reduces hepatocyte lipid content by increasing beta-oxidation

Ester Ciociola, Tanmoy Dutta, Kavitha Sasidharan, Lohitesh Kovooru, Francesca R. Noto, Grazia Pennisi, Salvatore Petta, Angela Mirarchi, Samantha Maurotti, Bernardette Scopacasa, Luca Tirinato, Patrizio Candeloro, Marcus Henricsson, Daniel Lindén, Oveis Jamialahmadi, Arturo Pujia, Rosellina M. Mancina, Stefano Romeo

Clin Mol Hepatol. 2025;31(2):445-459. Published online December 23, 2024

DOI: https://doi.org/10.3350/cmh.2024.0642

View: 3064 Download: 367 Web of Science: 2 Crossref: 3

Review

Liver organoids: Current advances and future applications for hepatology

Yohan Kim, Minseok Kang, Michael Girma Mamo, Michael Adisasmita, Meritxell Huch, Dongho Choi

Clin Mol Hepatol. 2025;31(Suppl):S327-S348. Published online December 26, 2024

DOI: https://doi.org/10.3350/cmh.2024.1040

View: 2688 Download: 304

Roles of X-box binding protein 1 in liver pathogenesis

Jihoon Tak, Yun Seok Kim, Sang Geon Kim

Clin Mol Hepatol. 2025;31(1):1-31. Published online October 2, 2024

DOI: https://doi.org/10.3350/cmh.2024.0441

View: 3043 Download: 189 Web of Science: 1 Crossref: 1

Letter to the Editor

Accountability in AI medicine: A critical appraisal of ChatGPT in patient self-management and screening

Jiawen Wang, Tian Xia

Clin Mol Hepatol. 2025;31(1):e1-e2. Published online September 26, 2024

DOI: https://doi.org/10.3350/cmh.2024.0769

View: 1187 Download: 50

Reply to Correspondence

Reply to correspondence on “Comparison of glucagon-like peptide-1 receptor agonists and thiazolidinediones on treating nonalcoholic fatty liver disease: a network meta-analysis”

Tian-Yi Ren, Mohammed Eslam, Jian-Gao Fan

Clin Mol Hepatol. 2024;30(4):1039-1041. Published online September 24, 2024

DOI: https://doi.org/10.3350/cmh.2024.0801

View: 1412 Download: 34

Reply to correspondence on “Protein-centric omics analysis reveals circulating complements linked to non-viral liver diseases as potential therapeutic targets”

Mohammad Saeid Rezaee-Zavareh, Naomy Kim, Ju Dong Yang

Clin Mol Hepatol. 2024;30(4):1037-1038. Published online May 2, 2024

DOI: https://doi.org/10.3350/cmh.2024.0320

View: 1869 Download: 56

Correspondence

Correspondence to editorial on “Protein-centric omics analysis reveals circulating complements linked to non-viral liver diseases as potential therapeutic targets”

Yingzhou Shi, Guandou Yuan, Xiude Fan, Chao Xu

Clin Mol Hepatol. 2024;30(4):987-988. Published online April 19, 2024

DOI: https://doi.org/10.3350/cmh.2024.0266

View: 1841 Download: 48

Harnessing hepatitis B core-related antigen measurement to optimize posttreatment monitoring

Ying-Nan Tsai, Jia-Ling Wu, Yao-Chun Hsu

Clin Mol Hepatol. 2024;30(2):293-296. Published online February 19, 2024

DOI: https://doi.org/10.3350/cmh.2024.0101

View: 2411 Download: 68

Editorial

Starting the journey: Understanding the roles of complement proteins in liver diseases through mendelian randomization

Mohammad Saeid Rezaee-Zavareh, Naomy Kim, Ju Dong Yang

Clin Mol Hepatol. 2024;30(2):150-153. Published online February 22, 2024

DOI: https://doi.org/10.3350/cmh.2024.0116

View: 4331 Download: 96 Web of Science: 5 Crossref: 5

Erratum

Erratum to ‘Correspondence on Letter regarding “Evidence-based hyponatremia management in liver disease”’ [Clin Mol Hepatol 2023;29:1048-1049]

Seon Ha Baek, Ji Young Ryu, Sejoong Kim

Clin Mol Hepatol. 2024;30(1):134-134. Published online November 7, 2023

DOI: https://doi.org/10.3350/cmh.2023.0261e
Corrects: Clin Mol Hepatol 2023;29(4):1048

View: 2221 Download: 39

Correspondence

Correspondence on Letter regarding “Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma”

Yee Hui Yeo, Ju Dong Yang

Clin Mol Hepatol. 2024;30(1):124-125. Published online November 14, 2023

DOI: https://doi.org/10.3350/cmh.2023.0470

View: 2696 Download: 57 Web of Science: 1 Crossref: 3

Letter to the Editor

Letter 2 regarding “Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma”

Yiwen Zhang, Liwei Wu, Zepeng Mu, Linlin Ren, Ying Chen, Hanyun Liu, Lili Xu, Yangang Wang, Yaxing Wang, Susan Cheng, Yih Chung Tham, Bin Sheng, Tien Yin Wong, Hongwei Ji

Clin Mol Hepatol. 2024;30(1):113-117. Published online November 10, 2023

DOI: https://doi.org/10.3350/cmh.2023.0440

View: 3287 Download: 90 Web of Science: 4 Crossref: 4

Letter 1 regarding “Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma”

Hinpetch Daungsupawong, Viroj Wiwanitkit

Clin Mol Hepatol. 2024;30(1):111-112. Published online October 13, 2023

DOI: https://doi.org/10.3350/cmh.2023.0394

View: 3010 Download: 73

Original Article

Protein-centric omics analysis reveals circulating complements linked to non-viral liver diseases as potential therapeutic targets

Yingzhou Shi, Hang Dong, Shiwei Sun, Xiaoqin Wu, Jiansong Fang, Jianbo Zhao, Junming Han, Zongyue Li, Huixiao Wu, Luna Liu, Wanhong Wu, Yang Tian, Guandou Yuan, Xiude Fan, Chao Xu

Clin Mol Hepatol. 2024;30(1):80-97. Published online December 7, 2023

DOI: https://doi.org/10.3350/cmh.2023.0343

View: 6298 Download: 249 Web of Science: 6 Crossref: 3

Snapshot

The role of the hepatic autonomic nervous system

Qiankun Luo, Pan Liu, Yifei Dong, Tao Qin

Clin Mol Hepatol. 2023;29(4):1052-1055. Published online July 25, 2023

DOI: https://doi.org/10.3350/cmh.2023.0244

View: 3752 Download: 88 Crossref: 1

Correspondence

Correspondence on Letter regarding “Evidence-based hyponatremia management in liver disease”

Ji Young Ryu, Seon Ha Baek, Sejoong Kim

Clin Mol Hepatol. 2023;29(4):1048-1049. Published online August 14, 2023

DOI: https://doi.org/10.3350/cmh.2023.0261 Correction in: Clin Mol Hepatol 2024;30(1):134

View: 2956 Download: 47

Letter to the Editor

Letter regarding “Evidence-based hyponatremia management in liver disease”

Daphne J. Theodorou, Stavroula J. Theodorou, Ioannis V. Mitselos

Clin Mol Hepatol. 2023;29(4):1043-1045. Published online July 5, 2023

DOI: https://doi.org/10.3350/cmh.2023.0204

View: 3415 Download: 40 Crossref: 1

Review

Evidence-based hyponatremia management in liver disease

Ji Young Ryu, Seon Ha Baek, Sejoong Kim

Clin Mol Hepatol. 2023;29(4):924-944. Published online June 5, 2023

DOI: https://doi.org/10.3350/cmh.2023.0090

View: 5908 Download: 315 Web of Science: 7 Crossref: 7

Correspondence

Correspondence on Letter 2 regarding “Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma”

Yee Hui Yeo, Jamil S. Samaan, Wee Han Ng

Clin Mol Hepatol. 2023;29(3):823-824. Published online May 31, 2023

DOI: https://doi.org/10.3350/cmh.2023.0182

View: 5718 Download: 56 Web of Science: 2 Crossref: 3

Correspondence on Letter 1 regarding “Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma”

Yee Hui Yeo, Jamil S. Samaan, Wee Han Ng

Clin Mol Hepatol. 2023;29(3):821-822. Published online May 31, 2023

DOI: https://doi.org/10.3350/cmh.2023.0183

View: 5703 Download: 79 Web of Science: 2 Crossref: 2

Letter to the Editor

Letter 2 regarding “Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma”

Amnuay Kleebayoon, Viroj Wiwanitkit

Clin Mol Hepatol. 2023;29(3):815-816. Published online May 24, 2023

DOI: https://doi.org/10.3350/cmh.2023.0170

View: 3078 Download: 62 Web of Science: 2 Crossref: 1

Letter 1 regarding “Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma”

Hassam Ali

Clin Mol Hepatol. 2023;29(3):813-814. Published online May 19, 2023

DOI: https://doi.org/10.3350/cmh.2023.0120

View: 3335 Download: 76 Web of Science: 1 Crossref: 2

Original Article

Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma

Yee Hui Yeo, Jamil S. Samaan, Wee Han Ng, Peng-Sheng Ting, Hirsh Trivedi, Aarshi Vipani, Walid Ayoub, Ju Dong Yang, Omer Liran, Brennan Spiegel, Alexander Kuo

Clin Mol Hepatol. 2023;29(3):721-732. Published online March 22, 2023

DOI: https://doi.org/10.3350/cmh.2023.0089

View: 28656 Download: 1,706 Web of Science: 357 Crossref: 369

Review

A decade of liver organoids: Advances in disease modeling

Yue Liu, Jian-Ying Sheng, Chun-Fang Yang, Junjun Ding, Yun-Shen Chan

Clin Mol Hepatol. 2023;29(3):643-669. Published online March 6, 2023

DOI: https://doi.org/10.3350/cmh.2022.0428

View: 11426 Download: 355 Web of Science: 11 Crossref: 11

Wnt signaling in liver regeneration, disease, and cancer

Gengyi Zou, Jae-Il Park

Clin Mol Hepatol. 2023;29(1):33-50. Published online July 4, 2022

DOI: https://doi.org/10.3350/cmh.2022.0058

View: 9682 Download: 307 Web of Science: 34 Crossref: 37

Original Article

Serum milk fat globule-EGF factor 8 protein as a potential biomarker for metabolic syndrome

Han Ah Lee, Jihwan Lim, Hyung Joon Joo, Young-Sun Lee, Young Kul Jung, Ji Hoon Kim, Hyunggin An, Hyung Joon Yim, Yoon Tae Jeen, Jong Eun Yeon, Do-Sun Lim, Kwan Soo Byun, Yeon Seok Seo

Clin Mol Hepatol. 2021;27(3):463-473. Published online February 15, 2021

DOI: https://doi.org/10.3350/cmh.2020.0351

View: 7752 Download: 181 Web of Science: 5 Crossref: 5

Editorial

Is liver biopsy still useful in the era of non-invasive tests?

Tae Seop Lim, Ja Kyung Kim

Clin Mol Hepatol. 2020;26(3):302-304. Published online July 1, 2020

DOI: https://doi.org/10.3350/cmh.2020.0081

View: 5778 Download: 144 Web of Science: 15 Crossref: 15

Original Article

Trends in the prevalence of chronic liver disease in the Korean adult population, 1998–2017

Seung Ha Park, Lindsay D. Plank, Ki Tae Suk, Yong Eun Park, Jin Lee, Joon Hyuk Choi, Nae Yun Heo, Jongha Park, Tae Oh Kim, Young Soo Moon, Hyun Kuk Kim, Hang Jea Jang, Ha Young Park, Dong Joon Kim

Clin Mol Hepatol. 2020;26(2):209-215. Published online November 4, 2019

DOI: https://doi.org/10.3350/cmh.2019.0065

View: 36007 Download: 430 Web of Science: 89 Crossref: 92

Editorial

A leap for the journal: Clinical and Molecular Hepatology enters a new era

Yoon Jun Kim

Clin Mol Hepatol. 2019;25(4):333-334. Published online December 17, 2019

DOI: https://doi.org/10.3350/cmh.2019.1004

View: 5323 Download: 58

Letter to the Editor

Biochemical profile in an infant with neonatal hemochromatosis shows evidence of impairment of mitochondrial long-chain fatty acid oxidation

Karina Lucio de Medeiros Bastos, Caio Robledo Quaio, Fabiana Roberto Lima, Iana Manuelle Araújo, Candice Alves Tavares Araújo, Flávia Balbo Piazzon, Ismael Dale Cotrim Guerreiro da Silva, Gabriel Nuncio Benevides, Ana Cristina Tannuri, Uenis Tannuri, Ramiro Anthero Azevedo, Chong Ae Kim

Clin Mol Hepatol. 2019;25(1):86-91. Published online August 28, 2018

DOI: https://doi.org/10.3350/cmh.2018.0005

View: 9387 Download: 151 Web of Science: 2 Crossref: 1

Viewed By 12651	Epidemiology of metabolic dysfunction-associated steatotic liver disease
Viewed By 7658	Radiogenomics of intrahepatic cholangiocarcinoma predicts immunochemotherapy response and identifies therapeutic target
Viewed By 7155	MAFLD: How is it different from NAFLD?
Viewed By 5707	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 5643	Hepatocellular carcinoma: updates on epidemiology, surveillance, diagnosis and treatment

Cited By 369	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 354	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 232	MAFLD: How is it different from NAFLD?
Cited By 122	Non-alcoholic fatty liver disease: Definition and subtypes
Cited By 116	Pathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis

Artificial intelligence, epidemiology, methodology, or others